$12m boost for peanut allergy treatment
Breakthrough Victoria has invested $12 million to progress Phase 2 clinical trials of a promising peanut allergy treatment, initially developed by Alfred Health and Monash University researchers.
Visitor information – Everything you need to know about visiting our sites.
Breakthrough Victoria has invested $12 million to progress Phase 2 clinical trials of a promising peanut allergy treatment, initially developed by Alfred Health and Monash University researchers.